Actinium Pharmaceuticals, Inc. (ATNM)
NYSEAMERICAN: ATNM · Real-Time Price · USD
1.510
+0.010 (0.67%)
Jun 23, 2025, 10:10 AM - Market open
Actinium Pharmaceuticals Market Cap
Actinium Pharmaceuticals has a market cap or net worth of $47.11 million as of June 23, 2025. Its market cap has decreased by -80.26% in one year.
Market Cap
47.11M
Enterprise Value
-17.10M
1-Year Change
-80.26%
Ranking
Category
Stock Price
$1.51
Market Cap Chart
Since December 27, 2012, Actinium Pharmaceuticals's market cap has increased from $16.70M to $47.11M, an increase of 182.07%. That is a compound annual growth rate of 8.66%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 20, 2025 | 46.80M | 19.08% |
| Dec 31, 2024 | 39.30M | -71.79% |
| Dec 29, 2023 | 139.30M | -48.67% |
| Dec 30, 2022 | 271.40M | 104.98% |
| Dec 31, 2021 | 132.40M | 24.91% |
| Dec 31, 2020 | 106.00M | 195.26% |
| Dec 31, 2019 | 35.90M | -19.87% |
| Dec 31, 2018 | 44.80M | -15.63% |
| Dec 29, 2017 | 53.10M | 8.81% |
| Dec 30, 2016 | 48.80M | -64.04% |
| Dec 31, 2015 | 135.70M | -23.20% |
| Dec 31, 2014 | 176.70M | 26.85% |
| Dec 31, 2013 | 139.30M | 734.13% |
| Dec 31, 2012 | 16.70M | - |
View and export this data all the way back to 2012.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 684.73B |
| Johnson & Johnson | 360.41B |
| AbbVie | 327.31B |
| Novo Nordisk | 326.28B |
| UnitedHealth Group | 273.97B |
| Abbott Laboratories | 231.38B |
| Novartis AG | 227.54B |
| AstraZeneca | 217.06B |